key: cord-0828107-9arxl3ry
authors: Castillo, Renan C.; Staguhn, Elena D.; Weston-Farber, Elias
title: The effect of state-level stay-at-home orders on COVID-19 infection rates
date: 2020-05-24
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2020.05.017
sha: c07399ba61a6c3236aae2cd6c9d516086c576534
doc_id: 828107
cord_uid: 9arxl3ry

State-level stay-at-home orders were monitored to determine their effect on the rate of confirmed COVID-19 diagnoses. Confirmed cases were tracked before and after state-level stay-at-home orders were put in place. Linear regression techniques were used to determine slopes for log case count data, and meta analyses were conducted to combine data across states. The results were remarkably consistent across states and support the usefulness of stay-at-home orders in reducing COVID-19 infection rates.

The emergence of the COVID-19 virus and the lack of therapeutic responses have led to widespread implementation of non-pharmaceutical interventions (NPIs) across the United States.

Substantial evidence exists for the effectiveness of NPIs in preventing the spread of infection. 1, 2 However, significant controversy still exists about the value and cost-benefit of these interventions in response to the current pandemic. Specifically, it is unclear what social isolation actions must be mandated by government policy to reach desired mitigation outcomes. 3 In response to the rising death toll associated with COVID-19, 42 states and the District of Columbia have implemented some variation of a state-wide stay-at-home order. In each case, there was controversy regarding the appropriateness of the order, and it is widely understood that these decisions incur human and economic costs. 4 In the current analysis, we present data from the states with stay-at-home orders and examine the effect of these policies on the rate of increase in COVID-19 diagnoses.

Google searches were conducted daily to assess state-level responses to the COVID-19 pandemic. Once stay-at-home orders were sighted, state government webpages were searched to confirm the dates that the orders went into effect. Forty-two states and the District of Columbia were identified to have issued a stay-at-home order between March 19, 2020 and April 7, 2020.

Stay-at-home orders were defined as statewide mandates that included a) mandatory nonessential business closures, b) furloughs enforced for most government and commercial employees, c) prohibition of public events and gatherings, and d) travel restrictions including orders to avoid leaving the home except for necessities such as groceries and medical care. 5 Daily confirmed COVID-19 cases were obtained from the Johns Hopkins Center for Health Security Application and downloaded via GitHub.

Analysis.

COVID-19 confirmed case counts were matched to stay-at-home order dates and divided into pre-order and post-order datasets for every state. Eight states without state-wide stay-at-home orders were excluded from this analysis. For the pre-and post-order sets, slopes were calculated from both raw and logged case count data using linear regression techniques and R2 fit statistics were obtained. As expected, R2 fits were substantially better for the logged data and this approach was used throughout the analysis. 95% confidence intervals were obtained for all parameters. Meta-analytic techniques were used to combine data across states using the METAN command suite in Stata. A sensitivity analysis was conducted using the same linear regression and meta-analytic approach to determine whether delaying the days counted as post-order by one week would impact the infection rates and R2 fit statistics. Table 1 displays the dates stay-at-home orders went into effect as well as logged, pre-order and post-order slopes and 95% confidence intervals for all 42 states and the District of Columbia. R2 fit statistics are also shown. In general, the fit of the slopes to the logged data is excellent, as would be expected from an exponentially growing pandemic in a naive population. The average rate of increase pre-order was 0.113 (95% C.I.: 0.110, 0.115) per day and post-order was 0.047 (95% C.I.: 0.045, 0.048) per day. Finally, and perhaps most importantly, a major limitation of this work is the endogenous relationship between case counts and both the availability and use of testing. The availability of testing was a significant barrier to COVID-19 diagnoses in the early stages of the pandemic in the U.S. and improved gradually over the month of March. Tests per day increased roughly tenfold between March 15th and March 31st and have increased at a more gradual rate of fourfold over the last six weeks. 6 We conducted an additional sensitivity analysis to examine whether the decrease in case incidence between pre-and post-order periods was different if the order occurred before or after April 1st and found the change in slopes to be nearly identical. As mentioned earlier, we also conducted a sensitivity analysis to account for the effect of time on these slopes and found no effect. Overall, the results must be interpreted in the context of this threat. Not only was the availability of tests evolving over this time period, but there is a direct relationship between the number of infections and public awareness of the pandemic and the number of tests performed. As such, it would be difficult to begin to parse out the effect of testing on the rate of incidence of COVID-19. That said, it is likely that the availability of tests may have an unmeasured impact on these results, but we cannot know if the impact was to increase or decrease the incidence rates. Despite these limitations, the consistency and strength of the results is notable. The results presented here will be updated daily and available for public download at www.hpmcovidpolicy.org.

Stay-at-home orders are generally supported by our results. This data is publicly available and provides daily updates on national infection rates. By tracking stay-at-home orders and the resulting infection rates, information is gathered on the effectiveness of such orders in mitigating the spread of COVID-19. The data may also inform policy and mitigation efforts for future infection outbreaks. Further research is needed to examine the effect of these policies in the longer term and in combination with other interventions.

Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base

Effectiveness of non-pharmaceutical measures in preventing pediatric influenza: a case-control study

How will countrybased mitigation measures influence the course of the COVID-19 epidemic? The Lancet

Spillover of COVID-19: Impact on the Global Economy

Governmental Public Health Powers During the COVID-19 Pandemic: Stay-at-home Orders, Business Closures, and Travel Restrictions

19-tests-per-day?time=2020-03-17..&country=United States, tests performed+USA